CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Operating expenses:
Research and development	$ 8,394	$ 5,340	$ 14,620	$ 12,077
General and administrative	5,676	5,374	10,740	10,625
Total operating expenses	14,070	10,714	25,360	22,702
Loss from operations	14,070	10,714	25,360	22,702
Other income, net:
Interest income	(3,364)	(3,158)	(6,797)	(6,063)
Other (income) expense	1	4	0	6
Total other income, net	(3,363)	(3,154)	(6,797)	(6,057)
Net loss	$ 10,707	$ 7,560	$ 18,563	$ 16,645
Net loss per share of common stock, basic	$ 0.26	$ 0.19	$ 0.46	$ 0.42
Net loss per share of common stock, diluted	$ 0.26	$ 0.19	$ 0.46	$ 0.42
Weighted-average number of common stock outstanding, basic	40,555,518	39,570,464	40,384,338	39,504,882
Weighted-average number of common stock outstanding, diluted	40,555,518	39,570,464	40,384,338	39,504,882